FDA Approves Potentially Groundbreaking Schizophrenia Drug 0 27.09.2024 18:50 Gizmodo.com On Thursday, the Food and Drug Administration approved Cobenfy, a drug from Bristol Myers Squibb—the first truly novel treatment for schizophrenia in decades. Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа
